Document:

Exhibit
10.10

 

THIS
WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”),
OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN SECTIONS 6.3 AND 6.4 BELOW, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE
TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND SUBSTANCE SATISFACTORY
TO THE COMPANY, SUCH OFFER, SALE, PLEDGE OR OTHER TRANSFER IS EXEMPT FROM SUCH REGISTRATION.

 

WARRANT
TO PURCHASE STOCK

 

This
WARRANT TO PURCHASE STOCK (as amended and in effect from time to time, this “Warrant”) is issued as of the issue date
set forth on Schedule I hereto (the “Issue Date”) by the company set forth on Schedule I hereto (the “Company”)
to SILICON VALLEY BANK in connection with that certain Deferral Agreement of even date herewith between them (as amended and/or modified
and in effect from time to time, the “Agreement”), and shall be transferred to SVB FINANCIAL GROUP pursuant to Section
6.4 below. The parties agree as follows:

 

SCHEDULE
I. WARRANT PROVISIONS.

 

	Warrant
    Section	 	Warrant
    Provision
	Recitals
    – “Issue Date”	 	April
    29, 2021.
	 	 	 
	Recitals
    – “Company”	 	Beamr
    Imaging Ltd, an Israeli private Company.
	 	 	 
	1.1
    – “Class”	 	At
    Banks’ discretion, either (i) Series C Preferred Stock, NIS0.01 par value per share, or (ii) the Next Equity Financing Securities.

     

    “Next
    Equity Financing Securities” means the class and series, or other designation, of convertible preferred stock or other
    equity security sold and issued by the Company in the Next Equity Financing.

	 	 	 
	1.1
    – “Exercise Price”	 	$1.024166667
    per Share, provided that if the Class is Next Equity Financing Securities, then the Exercise Price shall be the Next Equity Financing
    Price.

     

    “Next
    Equity Financing Price” means the lowest price per share for which Next Equity Financing Securities are sold or issued
    by the Company in the Next Equity Financing.

	 	 	 
	1.2
    – “Shares”	 	48,820
	 	 	 
	4.1(b)
    – Share percentage as of the Issue Date	 	0.08%
    of the Company’s total fully-diluted issued and outstanding shares of capital stock.
	 	 	 
	6.1(a)
    – “Expiration Date”	 	April
    29, 2036.

 

SECTION
1. RIGHT TO PURCHASE SHARES.

 

1.1 Grant
of Right. For good and valuable consideration, the Company hereby grants to SILICON VALLEY BANK (together with any successor or
permitted assignee or transferee of this Warrant or of any shares issued upon exercise hereof, “Holder”) the
right, and Holder is entitled, to purchase from the Company up to the number of fully paid and non-assessable shares (as determined
pursuant to Section 1.2 below) of the class set forth on Schedule I hereto (the “Class”), at a purchase price per
Share set forth on Schedule I hereto (the “Exercise Price”), subject to the provisions and upon the terms and
conditions set forth in this Warrant provided, that concurrently with the closing of the Next Equity Financing (or the date
that is seven (7) Business Days following Holder’s receipt of the Next Equity Financing Notice, if later), upon Holder’s
written election (in its sole discretion) to the Company delivered not later than two (2) days prior to such closing (or such later
date), the “Class” shall be Next Equity Financing Securities from and after such closing (or later date), subject to
adjustment thereafter from time to time in accordance with the provisions of this Warrant.

 

February
16, 2021

 

SVB Confidential

 

    

     

    

 

1.2
Number of Shares. This Warrant shall be exercisable for the number of shares of the Class as set forth on Schedule I hereto
(as may be adjusted from time to time in accordance with the provisions of this Warrant, the “Shares”).

 

SECTION
2. EXERCISE.

 

2.1
Method of Exercise. Holder may exercise this Warrant in whole or in part at any time and from time to time prior to the expiration
or earlier termination of this Warrant, by delivering to the Company the original of this Warrant together with a duly executed Notice
of Exercise in substantially the form attached hereto as Appendix 1 and, unless Holder is exercising this Warrant pursuant to
a cashless exercise set forth in Section 2.2 below, a check, wire transfer of same-day funds (to an account designated by the Company),
or other form of payment acceptable to the Company for the aggregate Exercise Price for the Shares being purchased. Notwithstanding any
contrary provision herein, to the extent that the original of this Warrant is an electronic original, in no event shall an original ink-signed
paper copy of this Warrant be required for any exercise of a Holder’s rights hereunder, nor shall this Warrant or any physical
copy hereof be required to be physically surrendered at the time of any exercise hereof.

 

2.2
Cashless Exercise. On any exercise of this Warrant, in lieu of payment of the aggregate Exercise Price in the manner specified
in Section 2.1 above, Holder may elect to surrender to the Company Shares having an aggregate value equal to the aggregate Exercise Price.
If Holder makes such election, the Company shall issue to Holder such number of fully paid and non-assessable Shares determined by the
following formula:

 

X
= Y(A-B)/A

 

where:

 

X
= the number of Shares to be issued to Holder;

 

Y
= the number of Shares with respect to which this Warrant is being exercised (inclusive of the Shares surrendered to the Company in payment
of the aggregate Exercise Price);

 

A
= the fair market value (as determined pursuant to Section 2.3 below) of one Share; and

 

B
= the Exercise Price, provided, that if the Exercise Price is adjusted pursuant to Section 2.6(c) of this Warrant, B shall equal the
par value of a Share.

 

2.3
Fair Market Value. If shares of the Company’s ordinary shares are then traded or quoted on a nationally recognized securities
exchange, inter-dealer quotation system or over-the-counter market (a “Trading Market”) and the Class is ordinary
shares, the fair market value of a Share shall be the closing price or last sale price of a share of the Company’s ordinary shares
reported for the Business Day immediately before the date on which Holder delivers this Warrant together with its Notice of Exercise
to the Company. If shares of the Company’s ordinary shares are then traded in a Trading Market and the Class is a series of the
Company’s convertible preferred stock, the fair market value of a Share shall be the closing price or last sale price of a share
of the Company’s ordinary shares reported for the Business Day immediately before the date on which Holder delivers this Warrant
together with its Notice of Exercise to the Company multiplied by the number of shares of the Company’s ordinary shares into which
a Share is then convertible. If shares of the Company’s ordinary shares are not then traded in a Trading Market, the Board of Directors
of the Company shall determine the fair market value of a Share of the Class in its reasonable good faith judgment, provided however,
that for purposes of determining the fair market value of a Share in connection with Automatic Cashless Exercise upon Expiration in accordance
with Section 5.1 below, the Board shall determine the fair market value of a Share based on the valuation prepared by a reputable independent
appraiser selected by the Holder with the consent of the Company (which consent shall not be unreasonably withheld), and whose fees and
expenses shall be borne by the Company.

 

    2

     

    

 

2.4
Delivery of Certificate and New Warrant. Within a reasonable time after Holder exercises this Warrant in the manner set forth
in Sections 2.1 or 2.2 above, the Company shall deliver to Holder a certificate (or, in the case of uncertificated securities, provide
notice of book entry) representing the Shares issued to Holder upon such exercise and, if this Warrant has not been fully exercised and
has not expired, a new warrant of like tenor representing the Shares not so acquired (or surrendered in payment of the aggregate Exercise
Price).

 

2.5
Replacement of Warrant.

 

(a)
Paper Original Warrant. To the extent that the original of this Warrant is a paper original, on receipt of evidence reasonably
satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant and, in the case of loss, theft or destruction,
on delivery of an indemnity agreement reasonably satisfactory in form, substance and amount to the Company or, in the case of mutilation,
on surrender of this Warrant to the Company for cancellation, the Company shall, within a reasonable time, execute and deliver to Holder,
in lieu of this Warrant, a new warrant of like tenor and amount.

 

(b)
Electronic Original Warrant. To the extent that the original of this Warrant is an electronic original, if at any time this Warrant
is rejected by any person (including, but not limited to, paying or escrow agents) or any such person fails to comply with the terms
of this Warrant based on this Warrant being presented to such person as an electronic record or a printout hereof, or any signature hereto
being in electronic form, the Company shall, promptly upon Holder’s request and without indemnity, execute and deliver to Holder,
in lieu of electronic original versions of this Warrant, a new warrant of like tenor and amount in paper form with original ink signatures.

 

2.6
Treatment of Warrant Upon Acquisition of Company.

 

(a)
Acquisition. “Acquisition” means any transaction or series of related transactions involving: (i) the sale,
lease, exclusive license, or other disposition of all or substantially all of the assets of the Company; (ii) any merger or consolidation
of the Company into or with another person or entity (other than a merger or consolidation effected exclusively to change the Company’s
domicile), or any other corporate reorganization, in which the stockholders of the Company in their capacity as such immediately prior
to such merger, consolidation or reorganization, own less than a majority of the Company’s (or the surviving or successor entity’s)
outstanding voting power immediately after such merger, consolidation or reorganization; or (iii) any sale or other transfer by the stockholders
of the Company of shares representing at least a majority of the Company’s then-total outstanding combined voting power. For the
avoidance of doubt, “Acquisition” shall not include any sale and issuance by the Company of shares of its capital stock or
of securities or instruments exercisable for or convertible into, or otherwise representing the right to acquire, shares of its capital
stock to one or more investors for cash in a transaction or series of related transactions the primary purpose of which is a bona fide
equity financing of the Company.

 

(b)
Treatment of Warrant in Cash/Public Acquisition. In the event of an Acquisition in which the consideration to be received by the
holders of the outstanding shares of the Class (in their capacity as such) consists solely of cash, solely of Marketable Securities (as
hereinafter defined) or a combination of cash and Marketable Securities (a “Cash/Public Acquisition”), and the fair
market value of one Share as determined in accordance with Section 2.3 above would be greater than the Exercise Price in effect as of
immediately prior to the closing of such Cash/Public Acquisition, and Holder has not previously exercised this Warrant in full, then,
in lieu of Holder’s exercise of the unexercised portion of this Warrant, this Warrant shall, as of immediately prior to such closing
(but subject to the occurrence thereof) automatically cease to represent the right to purchase Shares and shall, from and after such
closing, represent solely the right to receive the aggregate consideration that would have been payable in such Acquisition on and in
respect of all Shares for which this Warrant was exercisable as of immediately prior to the closing thereof, net of the aggregate Exercise
Price therefor, as if such Shares had been issued and outstanding to Holder as of immediately prior to such closing, as and when such
consideration is paid to the holders of the outstanding shares of the Class. In the event of a Cash/Public Acquisition in which the fair
market value of one Share as determined in accordance with Section 2.3 above would be equal to or less than the Exercise Price in effect
as of immediately prior to the closing of such Cash/Public Acquisition, then this Warrant will automatically and without further action
of any party terminate as of immediately prior to such closing.

 

    3

     

    

 

(c)
Treatment of Warrant in non-Cash/Public Acquisition. Upon the closing of any Acquisition other than a Cash/Public Acquisition,
either (i) the acquiring, surviving or successor entity shall assume this Warrant and the Company’s obligations hereunder, and
this Warrant shall thereafter be exercisable for the same securities and/or other property as would have been paid for the Shares issuable
upon exercise of the unexercised portion of this Warrant as if such Shares were outstanding on and as of the closing of such Acquisition,
at an aggregate Exercise Price equal to the aggregate Exercise Price in effect as of immediately prior to such closing, all subject to
further adjustment from time to time thereafter in accordance with the provisions of this Warrant; or (ii) if the successor or surviving
entity shall not have assumed this Warrant, then the Exercise Price shall be reduced to the par value of a Share as of immediately prior
to the closing of such Acquisition, and this Warrant shall be deemed to have been exercised in full pursuant to Section 2.2 above as
of immediately prior to the closing of such Acquisition.

 

(d)
Marketable Securities. “Marketable Securities” means securities meeting all of the following requirements (determined
as of immediately prior to the closing of the Acquisition): (i) the issuer thereof is then subject to the reporting requirements of Section
13 or Section 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and is then current in
its filing of all required reports and other information under the Act and the Exchange Act; (ii) the class and series of shares or other
security of the issuer that would be received by Holder in connection with the Acquisition were Holder to exercise this Warrant on or
prior to the closing thereof is then traded in a Trading Market, and (iii) following the closing of such Acquisition, Holder would not
be restricted from publicly re-selling all of the issuer’s shares and/or other securities that would be received by Holder in such
Acquisition were Holder to exercise this Warrant in full on or prior to the closing of such Acquisition, except to the extent that any
such restriction (x) arises solely under federal or state securities laws, rules or regulations, and (y) does not extend beyond six (6)
months from the closing of such Acquisition. Notwithstanding the foregoing provisions of this Section 2.6(d), securities held in escrow
or subject to holdback to cover indemnification-related claims shall be deemed to be Marketable Securities if they would otherwise be
Marketable Securities but for the fact that they are held in escrow or subject to holdback to cover indemnification-related claims.

 

2.7
Minimum Proceeds.

 

(a)
In the event that the Holder exercises this warrant and the Warrant Value (as defined below) is lower than the Minimum Value (as defined
below), then, immediately following such exercise, the Company shall pay the Holder, in cash, in addition to any other amounts due to
the Holder under the Loan Agreement (as defined under the Agreement) or otherwise, an amount equal to the difference between the Minimum
Value and the Warrant Value (the “Warrant Value Difference”).

 

(b)
For the purpose of this Section 2.7:

 

“Warrant
Value” shall mean (a) in case of cash exercise in accordance with subsection 2.1 above, – the Fair Market Value multiplied
by the number of Shares to be received by the Holder upon the cash exercise of this Warrant in full less the aggregate Exercise Price
paid by the Holder for the exercise of all such Shares; or (b) in case of a cashless exercise in accordance with subsection 2.2 above
– the Fair Market Value multiplied by the number of Shares to be received by the Holder upon the cashless exercise of this Warrant
in full (obtained by using the formula set forth in subsection 2.2 above).

 

“Minimum
Value” shall mean an amount of no less than $US50,000.

 

SECTION
3. CERTAIN ADJUSTMENTS TO THE SHARES, CLASS AND EXERCISE PRICE.

 

3.1
Stock Dividends, Splits, Etc. If the Company declares or pays a dividend or distribution on the outstanding shares of the Class
payable in additional shares of the Class (including fractional shares) or other securities or property (other than cash), then upon
exercise of this Warrant, for each Share acquired, Holder shall receive, without additional cost to Holder, the total number and kind
of securities and property which Holder would have received had Holder owned the Shares of record as of the date the dividend or distribution
occurred. If the Company subdivides the outstanding shares of the Class by reclassification or otherwise into a greater number of shares,
the number of Shares purchasable hereunder shall be proportionately increased, even if such number would include fractional shares, and
the Exercise Price shall be proportionately decreased. If the outstanding shares of the Class are combined or consolidated, by reclassification
or otherwise, into a lesser number of shares, the Exercise Price shall be proportionately increased and the number of Shares shall be
proportionately decreased, even if such number would include fractional shares.

 

    4

     

    

 

3.2
Reclassification, Exchange, Combination or Substitution. Upon any event whereby all of the outstanding shares of the Class are
reclassified, exchanged, combined, substituted, or replaced for, into, with or by Company securities of a different class and/or series,
then from and after the consummation of such event, “Class” shall mean such securities and this Warrant will be exercisable
for the number of such securities that Holder would have received had the Shares been outstanding on and as of the consummation of such
event, at an aggregate Exercise Price equal to the aggregate Exercise Price in effect as of immediately prior to such event, all subject
to further adjustment thereafter from time to time in accordance with the provisions of this Warrant. The provisions of this Section
3.2 shall similarly apply to successive reclassifications, exchanges, combinations, substitutions, replacements or other similar events.

 

3.3
Adjustment to Exercise Price on Cash Dividend. In the event that the Company at any time or from time to time prior to the exercise
in full of this Warrant pays any cash dividend on the outstanding shares of the Class or makes any cash distribution on or in respect
of all outstanding shares of the Class (other than a distribution of cash proceeds received by the Company in connection with an Acquisition
described in Section 2.6(a)(i) above), then on and as of the date of each such dividend payment and/or distribution, the Exercise Price
shall be reduced by an amount equal to the amount paid or distributed upon or in respect of each outstanding share of the Class; provided
that in no event shall the Exercise Price be reduced below the then-par value, if any, of a share of the Class.

 

3.4
No Fractional Share. No fractional Share shall be issued upon exercise of this Warrant, and the number of Shares to be issued
shall be rounded down to the nearest whole Share. If a fractional Share interest arises upon any exercise of this Warrant, the Company
shall eliminate such fractional Share interest by paying Holder in cash an amount equal to (a) such fractional interest, multiplied by
(b)(i) the fair market value (as determined in accordance with Section 2.3 above) of a full Share, less (ii) the then-effective Exercise
Price (the “Fractional Share Value”), unless Holder otherwise elects, in its sole discretion, to waive such payment.
Notwithstanding any contrary provision herein, if this Warrant becomes exercisable for a fractional Share interest at any time or from
time to time prior to the exercise in full of this Warrant, and the Company eliminates such fractional Share interest prior to any exercise
of this Warrant, then the then-effective Exercise Price shall be reduced by an amount equal to the Fractional Share Value, unless Holder
otherwise elects, in its sole discretion, to waive such reduction.

 

3.5
Certificate as to Adjustments. Within a reasonable time following each adjustment of the Exercise Price, Class and/or number of
Shares pursuant to the terms of this Warrant, the Company, at its expense, shall deliver a certificate of its Chief Financial Officer
or other authorized officer to Holder setting forth the adjustments to the Exercise Price, Class and/or number of Shares and the facts
upon which such adjustments are based. The Company shall, at any time and from time to time within a reasonable time following Holder’s
written request and at the Company’s expense, furnish Holder with a certificate of its Chief Financial Officer or other authorized
officer setting forth the then-current Exercise Price, Class and number of Shares and the computations or other determinations thereof.

 

3.6
Conversion of Preferred Shares. If the Class is a class and series of the Company’s convertible preferred shares, in the
event that all outstanding shares of the Class are converted, automatically or by action of the holders thereof, into ordinary shares
pursuant to the provisions of the Company’s Certificate of Incorporation as then in effect, including, without limitation, in connection
with the IPO (as hereinafter defined), then from and after the date on which all outstanding shares of the Class have been so converted,
this Warrant shall be exercisable for such number of shares of ordinary shares into which the Shares would have been converted had the
Shares been outstanding on the date of such conversion, and the Exercise Price shall equal the Exercise Price in effect as of immediately
prior to such conversion divided by the number of shares of ordinary shares into which one Share would have been converted, all subject
to further adjustment thereafter from time to time in accordance with the provisions of this Warrant.

 

3.7
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 3, the number
of shares of ordinary shares issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in
the manner set forth in the Company’s Articles of Association, as amended and in effect from time to time, as if the Shares were
issued and outstanding on and as of the date of any such required adjustment.

 

    5

     

    

 

3.8
Pay to Play Adjustments. Notwithstanding the definition of “Class” herein, if Pay to Play Provisions are at any time
during the term of this Warrant applied to the outstanding shares of the Class, then from and after such application, “Class”
shall mean that class and series of the Company’s securities that a holder of outstanding shares of the Class as of immediately
prior to such application would have received or retained had such holder participated in the manner necessary to receive or retain the
class and series of the Company’s securities having the relative rights, powers, privileges and preferences more favorable to the
holder. “Pay to Play Provisions” means provisions set forth in the Company’s Articles of Association or elsewhere
that require holders of the outstanding shares of the Class to participate in a subsequent round of equity financing of the Company or
lose all or a portion of the benefit of anti- dilution protection or any other right, power, privilege or preference applicable to such
shares or have such shares automatically convert to ordinary shares or another class or series of Company capital stock.

 

SECTION
4. REPRESENTATIONS AND COVENANTS OF THE COMPANY.

 

4.1
Representations and Warranties. The Company represents and warrants to, and agrees with, Holder as follows:

 

(a)
The price per share for which shares of the Class were last sold and issued for cash payment prior to the Issue Date hereof in an arms-length
transaction in which at least $500,000 of such shares were sold.

 

(b)
The Shares for which this Warrant is exercisable on and as of the Issue Date hereof represents not less than the share percentage set
forth on Schedule I hereto, calculated on and as of the Issue Date hereof on a fully-diluted, ordinary shares -equivalent basis (but
without excluding shares of capital stock that are not convertible into shares of ordinary shares) assuming (i) the conversion into ordinary
shares of all outstanding securities and instruments (including, without limitation, securities deemed to be outstanding pursuant to
clause (ii) of this Section SECTION 1(b)) convertible by their terms into shares of ordinary shares (regardless of whether such securities
or instruments are by their terms now so convertible), (ii) the exercise in full of all outstanding options, warrants (including, without
limitation, this Warrant) and other rights to purchase or acquire shares of ordinary shares or securities exercisable for or convertible
into shares of ordinary shares (regardless of whether such options, warrants or other rights to purchase or acquire are by their terms
now exercisable); and (iii) the inclusion of all shares of ordinary shares reserved for issuance under all of the Company’s incentive
stock and stock option plans and not now subject to outstanding grants or options.

 

(c)
All Shares which may be issued upon the exercise of this Warrant (and all securities issued on conversion of such Shares, if any), shall,
upon issuance, be duly authorized, validly issued, fully paid and non- assessable, and free of any liens and encumbrances except for
restrictions on transfer provided for herein or under the Company’s Certificate of Incorporation or Bylaws, each as amended and
in effect from time to time (the “Charter Documents”), any Stockholder Agreement (to the extent Holder is then a party
thereto or otherwise subject thereto in accordance with the provisions of Section 5.4 below) or applicable federal and state securities
laws. The Company covenants that it shall at all times cause to be reserved and kept available out of its authorized and unissued capital
stock such number of shares of the Class and other securities as will be sufficient to permit the exercise in full of this Warrant (and
conversion of the Shares, if applicable).

 

(d)
The Company’s capitalization table attached hereto as Appendix 3 is true and complete, in all material respects, as of the
Issue Date.

 

4.2
Notice of Certain Events. If the Company proposes at any time to:

 

(a)
declare any dividend or distribution upon the outstanding shares of the Class (or on the outstanding shares of ordinary shares), whether
in cash, stock or other securities or property and whether or not a regular cash dividend;

 

(b)
offer for subscription or sale pro rata to all holders of the outstanding shares of the Class (or on the outstanding shares of ordinary
shares) any additional securities of the Company (other than pursuant to contractual pre-emptive or first refusal rights);

 

(c)
effect any redemption, reclassification, exchange, combination, substitution, reorganization or recapitalization of the outstanding shares
of the Class (or on the outstanding shares of ordinary shares);

 

    6

     

    

 

(d)
effect an Acquisition, or to liquidate, dissolve or wind up the Company; or

 

(e)
effect its initial, underwritten offering and sale of its securities to the public pursuant to an effective registration statement under
the Act (the “IPO”);

 

then, in connection with each such event, the Company shall give Holder (pursuant to Section
6.5 below):

 

		(1)	in
                                            the case of the matters referred to in (a) and (b) above, at least seven (7) Business Days
                                            prior written notice of the earlier to occur of the effective date thereof or the date on
                                            which a record will be taken for such dividend, distribution, or subscription rights (and
                                            specifying the date on which the holders of outstanding shares of the Class (or of the outstanding
                                            shares of ordinary shares) will be entitled thereto) or for determining rights to vote, if
                                            any;

 

		(2)	in
                                            the case of the matters referred to in (c) and (d) above, at least seven (7) Business Days
                                            prior written notice of the date when the same will take place (and specifying the date on
                                            which the holders of outstanding shares of the Class (or of the outstanding shares of ordinary
                                            shares) will be entitled to exchange their shares for the securities or other property deliverable
                                            upon the occurrence of such event and such reasonable information as Holder may reasonably
                                            require regarding the treatment of this Warrant in connection with such event giving rise
                                            to the notice); and

 

		(3)	with
                                            respect to the IPO, at least seven (7) Business Days prior written notice of the date on
                                            which the Company proposes to make the first public filing of its registration statement
                                            in connection therewith.

 

4.3
Certain Company Information. The Company will provide such information requested by Holder from time to time, within a reasonable
time following each such request, that is reasonably necessary to enable Holder to comply with Holder’s accounting or reporting
requirements. Prior to the IPO, such information may include, but shall not be limited to, the Company’s then-current summary capitalization
table, the price per share for which the Company most recently prior thereto sold or issued shares of its convertible preferred stock
to investors for cash in a bona fide equity financing of the Company, and the Company’s most recent 409A Valuation.

 

4.4
Next Equity Financing Notice. The Company shall provide written notice to Holder not less than seven (7) Business Days prior to
the anticipated closing of the Next Equity Financing, which notice shall state all material terms and conditions thereof and all material
rights, power, preferences and privileges of the Next Equity Financing Securities (the “Next Equity Financing Notice”).
Following delivery of such Next Equity Financing Notice, the Company shall promptly provide to Holder such copies of the draft and execution
versions of the transaction documents in connection with the Next Equity Financing (including, without limitation, the Company’s
amended and/or restated Certificate of Incorporation, the securities purchase agreement and pre and post-closing capitalization tables)
as Holder shall request from time to time.

 

SECTION
5. REPRESENTATIONS AND COVENANTS OF HOLDER.

 

Holder
represents and warrants to, and agrees with, the Company as follows:

 

5.1
Investment Representations.

 

(a)
Purchase for Own Account. Except for the one-time transfer of this Warrant from Silicon Valley Bank to its parent SVB Financial
Group described in Section 6.4 below, this Warrant and the Shares to be acquired upon exercise hereof (and the securities issuable on
conversion of such Shares, if any) are being acquired for investment for Holder’s account, not as a nominee or agent, and not with
a view to the public resale or distribution within the meaning of the Act. Holder also represents that it has not been formed for the
specific purpose of acquiring this Warrant or the Shares.

 

    7

     

    

 

(b)
Disclosure of Information. Holder is aware of the Company’s business affairs and financial condition and has received or
has had full access to all the information it considers necessary or appropriate to make an informed investment decision with respect
to the acquisition of this Warrant and its underlying securities. Holder further has had an opportunity to ask questions of and receive
answers from the Company regarding the terms and conditions of the offering of this Warrant and its underlying securities and to obtain
additional information (to the extent the Company possessed such information or could acquire it without unreasonable effort or expense)
necessary to verify any information furnished to Holder or to which Holder has access.

 

(c)
Investment Experience. Holder understands that the purchase of this Warrant and its underlying securities involves substantial
risk. Holder has experience as an investor in securities of companies in the development stage and acknowledges that Holder can bear
the economic risk of such Holder’s investment in this Warrant and its underlying securities for an indefinite period of time, and
has such knowledge and experience in financial or business matters that Holder is capable of evaluating the merits and risks of its investment
in this Warrant and its underlying securities and/or has a preexisting personal or business relationship with the Company and certain
of its officers, directors or controlling persons of a nature and duration that enables Holder to be aware of the character, business
acumen and financial circumstances of such persons.

 

(d)
Accredited Investor Status. Holder is an “accredited investor” within the meaning of Regulation D promulgated under
the Act.

 

(e)
The Act. Holder understands that this Warrant and the Shares issuable upon exercise hereof (and the securities issuable on conversion
of such Shares, if any) have not been registered under the Act or registered or qualified under the securities laws of any state, and
are issued in reliance upon specific exemptions therefrom, which exemptions depend upon, among other things, the bona fide nature of
the Holder’s investment intent as expressed herein. Holder understands that the Company is under no obligation to so register or
qualify this Warrant, the Shares or such other securities. Holder understands that this Warrant and the Shares issued upon any exercise
hereof (and the securities issuable on conversion of such Shares, if any) are “restricted securities” under applicable federal
and state securities laws and must be held indefinitely unless subsequently registered under the Act and registered or qualified under
applicable state securities laws, or unless exemptions from such registration and qualification are otherwise available. Holder is aware
of the provisions of Rule 144 promulgated under the Act.

 

5.2
No Stockholder Rights. Without limiting any provision of this Warrant, Holder agrees that as a Holder of this Warrant it will
not have any rights (including, but not limited to, voting rights) as a stockholder of the Company with respect to the Shares issuable
hereunder (or the securities issuable on conversion of such Shares, if any) unless and until the exercise of this Warrant and then only
with respect to the Shares issued on such exercise (or the securities issued on conversion of such Shares, if any).

 

5.3
Market Stand-off Agreement. The Holder agrees that the Shares (and the securities issuable on conversion of such Shares, if any)
shall be subject to the Market Standoff provisions in Section          of the Company’s
Investor Rights Agreement or similar agreement, as amended and in effect from time to time.

 

5.4
Stockholder Agreements. Following any exercise of this Warrant and solely with respect to the Shares issued thereupon, if the
Company so requests in writing, Holder shall become a party to the Company’s then- effective right of first refusal and co-sale
agreement, voting agreement and/or each other agreement entered into among the Company and holders of the outstanding shares of the Class,
each as may be amended and in effect from time to time (collectively, the “Stockholder Agreements”), by execution
and delivery to the Company of a counterpart signature page, joinder agreement, instrument of accession or similar instrument, provided
that such Stockholder Agreement is by its terms in force and effect at the time of such exercise. If the foregoing condition is met,
then effective upon such exercise, Holder shall automatically become bound by, and the Shares issued upon such exercise (and the securities
issuable on conversion of such Shares, if any) shall automatically become subject to, such Stockholder Agreement.

 

5.5
Confidential Information. Holder agrees to treat and hold all information provided by the Company pursuant to this Warrant in
confidence in accordance with the provisions of Section            of the
Loan Agreement (as defined under the Agreement) (regardless of whether the Loan Agreement (as defined under the Agreement) shall then
be in effect).

 

    8

     

    

 

SECTION
6. MISCELLANEOUS.

 

6.1
Term; Automatic Cashless Exercise Upon Expiration.

 

(a)
Term. Subject to the provisions of Section 2.6 above, this Warrant is exercisable in whole or in part at any time and from time
to time on or before 6:00 PM, Pacific time, on the expiration date set forth on Schedule I hereto (the “Expiration Date”)
and shall be void thereafter; provided that if the Company does not deliver to Holder written confirmation of the fair market value of
a Share of the Class pursuant to Section SECTION 6(b) below, then the Expiration Date shall automatically be extended until the earlier
to occur of (i) such date as the Company delivers such written confirmation and (ii) one (1) year after the Expiration Date.

 

(b)
Automatic Cashless Exercise upon Expiration. In the event that, upon the Expiration Date, the fair market value of one Share as
determined in accordance with Section 2.3 above is greater than the Exercise Price in effect on such date, then this Warrant shall automatically
be deemed on and as of such date to be exercised pursuant to Section 2.2 above as to all Shares for which it shall not previously have
been exercised, and the Company shall, within a reasonable time following Holder’s written request, deliver a certificate (or,
in the case of uncertificated securities, provide notice of book entry) representing the Shares issued to Holder upon such exercise.
If shares of the Company’s ordinary shares are not then traded in a Trading Market, the Company shall deliver to Holder, prior
to the Expiration Date, written confirmation of the fair market value of a Share of the Class (as determined pursuant to Section 2.3
above) to be used in determining whether this Warrant shall automatically exercise on the Expiration Date pursuant to this Section SECTION
6(b).

 

6.2
Legends. Each certificate or notice of book entry evidencing Shares (and the securities issuable on conversion of such Shares,
if any) shall be imprinted with a legend in substantially the following form (together with such additional legends as may be required
by the Charter Documents or under any Stockholder Agreement (to the extent Holder is then a party thereto or otherwise subject thereto
in accordance with the provisions of Section 5.4 above)):

 

THE
SHARES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”),
OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN THAT CERTAIN WARRANT TO PURCHASE STOCK ISSUED BY THE ISSUER TO SILICON
VALLEY BANK DATED APRIL 29, 2021, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT
AND LAWS OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER, SUCH OFFER, SALE, PLEDGE OR OTHER TRANSFER
IS EXEMPT FROM SUCH REGISTRATION.

 

And,
if then applicable, a legend in substantially the following form:

 

THE
SECURITIES EVIDENCED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN RESTRICTIONS ON TRANSFERABILITY AND RESALE, INCLUDING A LOCK-UP PERIOD
AFTER THE EFFECTIVE DATE OF THE ISSUER’S REGISTRATION STATEMENT FILED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AS SET FORTH
IN THAT CERTAIN WARRANT TO PURCHASE STOCK ISSUED BY THE ISSUER TO SILICON VALLEY BANK DATED APRIL 29, 2021, A COPY OF WHICH MAY BE OBTAINED
AT THE ISSUER’S PRINCIPAL OFFICE. SUCH RESTRICTIONS ARE BINDING ON TRANSFEREES OF THESE SECURITIES.

 

6.3
Compliance with Securities Laws on Transfer. This Warrant and the Shares issued upon exercise hereof (and the securities issued
on conversion of such Shares, if any) may not be transferred or assigned in whole or in part except in compliance with applicable federal
and state securities laws by the transferor and the transferee (including, without limitation, the delivery of investment representation
letters and legal opinions reasonably satisfactory to the Company, as reasonably requested by the Company). The Company shall not require
Holder to provide an opinion of counsel if the transfer is to SVB Financial Group (Silicon Valley Bank’s parent company) or any
other affiliate of Holder; provided that any such transferee is an “accredited investor” as defined in Regulation D promulgated
under the Act.

 

    9

     

    

 

6.4
Transfer Procedure. After receipt by Silicon Valley Bank of the executed Warrant, Silicon Valley Bank will transfer, for value
received, all of its rights, title and interest in and to this Warrant to its parent company, SVB Financial Group, without any separate
assignment agreement. By its acceptance of this Warrant, SVB Financial Group, on and as of the date of such assignment, hereby makes
to the Company each of the representations and warranties set forth in Section SECTION 5 hereof and agrees to be bound by all of the
terms and conditions of this Warrant as if it were the original Holder hereof. Subject to the provisions of Section 6.3 and upon providing
the Company with written notice, SVB Financial Group and any subsequent Holder may transfer all or part of this Warrant or the Shares
issued upon exercise of this Warrant to any transferee; provided that in connection with any such transfer, SVB Financial Group or any
subsequent Holder will give the Company notice of the portion of the Warrant and/or Shares (and/or securities issued on conversion of
such Shares, if any) being transferred with the name, address and taxpayer identification number of the transferee, and Holder will surrender
this Warrant, or the certificates or other evidence of such Shares or other securities, to the Company for reissuance to the transferee(s)
(and to Holder if applicable); and provided further, that any subsequent transferee other than SVB Financial Group shall make substantially
the representations set forth in Section SECTION 5 above and shall agree in writing with the Company to be bound by all of the terms
and conditions of this Warrant; and provided further, that the transfer of any Shares issued on exercise hereof (or of any securities
issued on conversion of such Shares) shall be subject to the provisions of the Stockholder Agreements to the extent Holder is then a
party thereto or otherwise subject thereto in accordance with the provisions of Section 5.4 above. Notwithstanding any contrary provision
herein, at all times prior to the IPO, Holder may not, without the Company’s prior written consent, transfer this Warrant or any
portion hereof, or any Shares issued upon any exercise hereof (or any securities issued on conversion of such Shares) to any person or
entity who directly competes with the Company (as determined by the Company’s Board of Directors in its reasonable good faith judgment),
except in connection with an Acquisition of the Company by such a direct competitor.

 

6.5
Notices. All notices and other communications hereunder from the Company to the Holder, or vice versa, shall be deemed delivered
and effective (i) when given personally, (ii) on the third (3rd) Business Day after being mailed by first-class registered or certified
mail, postage prepaid, (iii) upon actual receipt if given by electronic mail and such receipt is confirmed in writing by the recipient,
or (iv) on the first Business Day following delivery to a reliable overnight courier service, courier fee prepaid, in any case at such
address as may have been furnished to the Company or Holder, as the case may be, in writing by the Company or such Holder from time to
time in accordance with the provisions of this Section 6.5. All notices to Holder shall be addressed as follows until the Company receives
notice of a change of address in connection with a transfer or otherwise:

 

SVB
Financial Group 

Attn: Warrants

80
East Rio Salado Parkway, Suite 600 

Tempe, AZ 85281

Telephone: (480) 557-4900 

Email: SVBFGWarrants@svb.com

 

All
notices to the Company shall be addressed as follows until Holder receives notice of a change in address:

 

Sharon
Carmel

Attn: Chief executive officer 

Telephone: _______________

Email: sharon@beamr.com

 

With
a copy (which shall not constitute notice) to:

 

________________________

Attn:
____________________

________________________

Telephone:
_______________

Email:
___________________

 

6.6
Amendment and Waiver. Notwithstanding any contrary provision herein or in the Loan Agreement (as defined under the Agreement),
this Warrant may be amended and any provision hereof waived (either generally or in a particular instance and either retroactively or
prospectively) only by an instrument in writing signed by Holder and any party against which enforcement of such amendment or waiver
is sought.

 

    10

     

    

 

6.7
Counterparts; Electronic Signatures; Status as Certificated Security. This Warrant may be executed by one or more of the parties
hereto in any number of separate counterparts, all of which together shall constitute one and the same instrument. The Company, Holder
and any other party hereto may execute this Warrant by electronic means and each party hereto recognizes and accepts the use of electronic
signatures, including any Electronic Signature as defined in the Electronic Transactions Law (2003 Revision) of the Cayman Islands (the
“Cayman Islands Electronic Signature Law”),] and the keeping of records in electronic form[, including any Electronic
Record, as defined in Cayman Islands Electronic Signature Law,] by any other party hereto in connection with the execution and storage
hereof. To the extent that this Warrant or any agreement subject to the terms hereof or any amendment hereto is executed, recorded or
delivered electronically, it shall be binding to the same extent as though it had been executed on paper with an original ink signature,
as provided under applicable law, including, without limitation, any state law based on the Uniform Electronic Transactions Act or the
Cayman Islands Electronic Signature Law; provided that Sections 8 and 19(3) of the Cayman Islands Electronic Signature Law shall not
apply to this Warrant or the execution or delivery hereof. The fact that this Warrant is executed, signed, stored or delivered electronically
shall not prevent the transfer by any Holder of this Warrant pursuant to Section 6.4 or the enforcement of the terms hereof. To the extent
that the original of this Warrant is an electronic original, this Warrant, and any copies hereof, shall NOT be deemed to be a “certificated
security” within the meaning of Section 8102(a)(4) of the California Commercial Code. Physical possession of the original of this
Warrant or any paper copy thereof shall confer no special status to the bearer thereof.

 

6.8 Tax.

 

(a)
Holder shall bear full responsibility for all tax obligations and consequences relating to the issuance, transfer or exercise of this
Warrant or sale of the Shares issuable upon the exercise of this Warrant, which by their nature apply to holders of warrants. In the
event that the Company is required under applicable law to withhold any tax as a result of the exercise of this Warrant and/or the issuance
of the Shares underlying the Warrant, the Company will be entitled to withhold such taxes in accordance with applicable law; provided,
however, that if Holder provides the Company with a valid certificate of exemption from tax withholding or a determination applying
a reduced withholding tax rate or any other instructions regarding the payment of withholding taxes issued by the Israel Tax Authority,
then such withholding (if any) shall be made only in accordance with the provisions of such certificate.

 

(b)
In the event that the Company is required under Israeli law to withhold taxes in connection with the exercise of this Warrant and/or
the issuance of the Shares underlying the Warrant in accordance with the provisions of Section (a) above, the Company shall be entitled
to (i) deduct such amounts actually paid by the Company to the Israeli Tax Authority from any cash consideration payable to the Holder
as a result of such exercise and/or issuance, as the case may be, or (ii) absent of such sufficient cash consideration, the Holder shall
reimburse the Company for such shortfall of cash amount actually withheld by the Company and paid to the applicable Israeli tax authority;
in each case provided that: (i) prior to making any tax withholding payment, the Company shall advise Holder in writing of such
proposed payment in order to allow Holder to present to the Company a valid certificate of exemption from tax withholding or a determination
applying a reduced withholding tax rate or any other instructions regarding the payment of withholding taxes issued by the Israel Tax
Authority, (ii) in connection with the tax withheld by the Company, if any, the Company will furnish Holder with proof reasonably satisfactory
to Holder indicating that the Company has made all such withholding tax payments, and (iii) the Company will cooperate with Holder in
connection with any information and documentation reasonably required by Holder in connection with credits, exemptions, rebates, or other
benefits to be obtained by Holder in connection with such withholding payments made by the Company, which credits, exemptions, rebates,
or other benefits shall be property of the Holder.

 

6.9
Headings. The headings in this Warrant are for purposes of reference only and shall not limit or otherwise affect the meaning
of any provision of this Warrant.

 

6.10
Business Days. “Business Day” means any day that is not a Saturday, Sunday or a day on which banks in California
are closed.

 

SECTION
7. GOVERNING LAW, VENUE AND JURY TRIAL WAIVER; JUDICIAL REFERENCE.

 

7.1
Governing Law. This Warrant shall be governed by and construed in accordance with the laws of the State of Israel, without giving effect
to its principles regarding conflicts of law, and the parties hereto irrevocably submit to the exclusive jurisdiction of the Courts of
Tel Aviv, Israel, in respect of any dispute or matter arising out of or connected with this Warrant. This Section 7.1 shall survive the
termination of this Warrant

 

7.2
Survival. This Section 7 shall survive the termination of this Warrant.

 

[Signature
page follows]

 

    11

     

    

 

IN
WITNESS WHEREOF, the parties have caused this Warrant to Purchase Stock to be executed by their duly authorized representatives effective
as of the Issue Date written above.

 

	 	COMPANY:
	 	 
	 	BEAMR IMAGING LTD
	 	 
	 	By: 	/s/ Sharon
    Carmel
	 	Name:	Sharon Carmel
	 	Title: 	CEO
	 	 
	 	HOLDER:
	 	 
	 	SILICON VALLEY BANK
	 	 
	 	By: 	/s/ Ella Botham
	 	Name: 	Ella Botham
	 	Title:	Vice President

 

    12

     

    

 

APPENDIX
1

 

Form
of Notice of Exercise of Warrant

 

1.
The undersigned Holder hereby exercises its right to purchase                     
shares of the [Ordinary / Series                  
Preferred] Shares of                                (the
“Company”) in accordance with the attached Warrant To Purchase Stock, and tenders payment of the aggregate Exercise
Price for such shares as follows:

 

	 	☐	Check in the amount of $_______ payable to order of
    the Company enclosed herewith
	 	 	 
	 	☐	Wire transfer of immediately available funds to the
    Company’s account
	 	 	 
	 	☐	Cashless exercise pursuant to Section 2.2 of the Warrant,
    resulting in the issuance of __________ shares of the [Common] / [Series _______ Preferred] [circle one] Stock of the Company
	 	 	 
	 	☐	Other [Describe]                                                                                                                                 

 

2. Please
issue a certificate or certificates (or evidence of book entry) representing the Shares in the name specified below:

 

	 	 	 
	 	Holder’s
    Name	 
	 	 	 
	 	 	 
	 	(Address)	 

 

3.
By its execution below and for the benefit of the Company, Holder hereby makes each of the representations and warranties set forth in
Section SECTION 5 of the Warrant To Purchase Stock as of the date hereof.

 

	 	HOLDER:
	 	 
	 	 
	 	By: 	                                      
	 	Name: 	 
	 	Title: 	 
	 	 	 
	 	(Date): 	 

 

    Appendix 1Exhibit
10.11

 

ADVANCE
INVESTMENT AGREEMENT

 

THIS
ADVANCE INVESTMENT AGREEMENT (this “Agreement”) is entered into as of August 26, 2021, by and between Beamr Imaging
Ltd., a company organized under the laws of the State of Israel (the “Company”) and the Investor listed in Schedule
1 attached hereto (the “Investor”).

 

WHEREAS,
the Investor has agreed to provide the Company with a bridge investment in the aggregate amount of US$                                                 (the
“Investment Amount”); and

 

WHEREAS,
the Company desires to receive from the Investor the Investment Amount, and the Investor is willing, to provide the Investment Amount
to the Company, subject to the terms and conditions of this Agreement.

 

NOW,
THEREFORE, THE PARTIES HEREBY AGREE AS FOLLOWS:

 

1.
THE INVESTMENT AMOUNT. At and subject to the Closing (as defined below), the Investor shall provide to the Company and the Company
shall receive from the Investor the Investment Amount.

 

2.
CLOSING.

 

2.1
Closing Date. Subject to the fulfillment of the conditions set forth in Section 7 below, the closing of the payment and receipt
of the Investment Amount (the “Closing”) shall take place remotely, via the exchange of documents and signatures,
on the date hereof, or by such other means or at such other date or place as may be agreed by the Investor and the Company (the date
on which the Closing actually occurs, the “Closing Date”).

 

2.2
Transactions at the Closing. At the Closing, the following transactions shall occur, which transactions shall be deemed to take
place simultaneously and no transaction shall be deemed to have been completed or any document delivered until all such transactions
have been completed and all required documents delivered:

 

 (a) The Company shall deliver to the Investor the following documents:

 

(i)
True and correct copies of the resolutions of the Company’s Board of Directors approving, inter alia, this Agreement and
the transactions contemplated hereby, in the form attached hereto as Schedule 2.2(a)(i);

 

(ii)
Waivers of rights of preemption or other participation rights (including with respect to the conversion of the Investment Amount pursuant
to the terms and conditions hereunder), executed by all shareholders entitled to such rights under the Company’s Articles of Association
as in effect as of the date hereof (the “Existing Articles”) or otherwise evidence that such rights have expired;
and

 

(b)
The Investor shall cause the transfer to the Company of the Investment Amount, by wire transfer, or such other form of payment as is
mutually agreed by the Company and the Investor, to such bank account as the Company shall instruct the Investor in writing.

 

 3.  ISSUANCE
OF SHARES.

 

3.1 Issuance
upon Qualified Financing.

 

(a)
In the event of the consummation by the Company of a transaction or series of related transactions in which the Company issues
securities of a preferred class or series, in consideration for an aggregate investment of at least US$10,000,000 (Ten Million
United States Dollars) (including the Investment Amount and any additional amount provided to the Company under any additional
Advanced Investment Agreement(s)) (a “Qualified Financing”), the Investment Amount shall automatically convert
immediately prior to the consummation of such Qualified Financing into such number of preferred shares (or a sub-class thereof)
issued in such Qualified Financing (the “Next Round Shares”), as is obtained by dividing the Investment Amount by
a price per share which shall reflect a 20% discount off the lowest price per share paid in the Qualified Financing.

 

     

     

    

 

(b)
The shares issued upon conversion of the Investment Amount (the applicable shares issued upon conversion under each of the conversion
provisions of this Agreement are referred to herein as the “Conversion Shares”) shall have the same rights and preferences
as attached to the shares issued to the investors in such Qualified Financing (but not, for the avoidance of doubt, the right to nominate
a director to the extent such right had not existed previously)), including without limitation, liquidation preference, anti-dilution
protection, registration rights, preemptive rights, right of first refusal, voting and veto rights, or other rights, pro-rata to the
respective amounts of investment, and the Investor shall otherwise be deemed one of the investors in such Qualified Financing for all
purposes (including with respect to any other securities, warrants or other rights issued or provided to all such investors as part of
the Qualified Financing).

 

(c)
In the event that the Qualified Financing is achieved through a series of related closings, then: (i) the Investment Amount shall be
converted as aforesaid, at the first closing to occur, at which all conditions required to qualify such financing as a Qualified Financing
have been satisfied; and (ii) in the event that the transactions consummated in such closings are not on the same terms and conditions
and/or involve the issuance of more than one type of Company’s securities, then, the Investment Amount shall be converted as aforesaid
into an equity investment on the most favorable terms to the Investor, at the conversion price detailed in Section 3.1(a) above, as applicable,
with the securities issued therefor being of the type that confers upon its holders the most favorable and preferential rights, preferences
and privileges.

 

3.2
Issuance upon a Non-Qualified Financing. In the event of a consummation by the Company of a transaction or series of related transactions
in which the Company issues preferred shares in consideration for an aggregate investment of less than US$10,000,000 (Ten Million United
States Dollars) (including the Investment Amount and any additional amount provided to the Company under any additional Advanced Investment
Agreement(s)), or which for any other reason would not be deemed as a Qualified Financing (a “Non-Qualified Financing”),
then upon each time when the Company consummates such Non-Qualified Financing, the Investor shall have the right (but not the obligation)
to elect, by delivery of written notice to the Company no later than thirty (30) days from the receipt of a written notice from the Company
setting forth the terms and conditions of such Non-Qualified Financing, to convert immediately prior to the consummation of such Non-Qualified
Financing the Investment Amount into the shares and/or securities issued and sold at the closing of such Non-Qualified Financing, all
in accordance with the provisions of Section 3.1 above, which shall apply mutatis mutandis.

 

3.3
Issuance upon a Trigger Date. In the event that the Company has not consummated by August 26, 2022 (the “Trigger Date”)
a Qualified Financing or an Exit Event (as defined below) and the Investment Amount or any portion thereof has not been converted in
accordance with the terms of this Agreement, then, the Investor shall have the right (but not the obligation) to elect, by delivery of
written notice to the Company no later than thirty (30) days from the receipt of a written notice from the Company, to convert the Investment
Amount into such number of shares of the Company of the most senior class then outstanding (the “Most Senior Shares”),
equals to the quotient received by dividing the Investment Amount by a price per share reflecting a pre-money valuation of the Company
(determined on a fully diluted basis as of the date of the conversion) of US$62,500,000 (“Target Valuation”).

 

3.4 Issuance/Payment
upon an Acquisition or Asset Transfer. Unless previously converted, in the event of the consummation of an Acquisition or an
Asset Transfer (as such terms are defined in the Company’s Articles of Association, as may be amended from time to time (the
“Articles”)) (together with an IPO (as such term is defined in the Articles), each, an “Exit
Event”), then immediately prior to the closing of such Acquisition or Asset Transfer, the Investor shall either elect, at
its discretion, to (I) convert the Investment Amount into such number of Most Senior Shares, as is obtained by dividing the
Investment Amount by the quotient obtained by dividing (A) the Target Valuation by (B) the issued and outstanding share capital of
the Company, on a fully diluted basis, as of immediately prior to the closing of the Acquisition or Asset Transfer, as applicable,
excluding any shares to be issued under this Agreement); or (II) receive, prior and in preference to payment in respect of other
Company securities, a redemption payment equal to 200% of the Investment Amount.

 

    2

     

    

 

3.5
Issuance upon an IPO. Unless previously converted, in the event of the consummation of an IPO, then immediately prior to the closing
or effectiveness of the IPO, the Investment Amount shall be automatically converted into Ordinary Shares (as defined below) at a price
per share equal to the quotient of (i) the price to the public per Ordinary Share of the Company in such IPO multiplied by (ii) 0.8.

 

3.6
Notice. For as long as the Investment Amount has not been converted, the Company shall deliver prior written notice to the Investor
of any contemplated Qualified Financing, Non-Qualified Financing or Exit Event, as promptly as possible, but in any event at least fourteen
(14) days prior to the closing of such transaction, provided, however, that if such notice may not be given without the Company’s
breach of a confidentiality obligation entered into in connection with such contemplated transaction, or notice to the Company’s
shareholders is to be given at a later stage, then such notice shall be given at such times and on such terms as provided to the Company’s
shareholders.

 

 4.  MECHANICS
OF ISSUANCE OF SHARES.

 

4.1
No Fractional Shares. The issuance of shares hereunder shall be calculated based on the aggregate Investment Amount to be converted
by the Investor and upon conversion, no fractional shares shall be issued to the Investor. The number of Conversion Shares to be issued
to the Investor shall be rounded down to the nearest whole number.

 

4.2
Issuance. The Company shall, immediately upon any conversion of the Investment Amount, issue and deliver to the Investor a certificate
representing the number of the Conversion Shares to which the Investor is entitled upon conversion of the Investment Amount, grant to
the Investor the rights, preferences, powers and privileges required to be granted in connection with such Conversion Shares, and register
the issuance of such Conversion Shares in the Investor’s name in the Company’s register of shareholders. The Investor, by
entering into this Agreement, consents to the placement of legend(s) on all securities issued hereunder with respect to restrictions
on transferability thereof in order to ensure compliance with applicable securities laws.

 

4.3
Rights as Shareholder. From the date of occurrence of a conversion as set forth in Section 3 and thereafter, whether or not the
Conversion Shares required to be issued to the Investor have actually been issued, the Investor shall be deemed to be the holder of such
Conversion Shares, and shall be deemed to have all rights, preferences, powers, privileges, restrictions, qualifications and limitations
required to be granted in connection with such Conversion Shares.

 

4.4
Original Issue Price. For purposes of liquidation and dividend preference rights, anti dilution rights and any other rights to
which the Investor may be entitled upon conversion of the Investment Amount, whether pursuant to the Articles or otherwise, the price
per share of the Conversion Shares shall be the price per share according to which the Investment Amount was actually converted (i.e.,
after taking into account any discount provided to the Investor pursuant to this Agreement).

 

4.5
Further Assurance. The Investor agrees and covenants that at any time and from time to time it will promptly execute and deliver
to the Company such further instruments and documents and shall perform such further acts as may reasonably be necessary to carry out
and give full effect to the provisions of this Agreement and the intentions of the parties as reflected hereby, including, without limitation,
to vote (and execute written resolutions) at any time in favor of an amendment to the Articles as then in effect in order to provide
for the creation, authorization and issuance of the Conversion Shares, and the reservation of sufficient Ordinary Shares nominal value
NIS0.01 per share of the Company (“Ordinary Shares”) for conversion thereof. The Company hereby undertakes to take
all necessary actions in its power and obtain all required approvals and consents so as to approve and adopt such amendment to its Articles.

 

4.6
Effect of Conversion. Upon conversion or repayment, as applicable, in full of the Investment Amount pursuant to the terms of this
Agreement and, if applicable, the grant to the Investor of the rights, preferences, powers and privileges required to be granted in connection
with the Conversion Shares, any obligations of the Company (other than the representations of the Company listed herein) towards the
Investor hereunder shall be deemed satisfied in full.

 

    3

     

    

 

4.7
Financing Agreements. The Investor acknowledges and agrees that the conversion of the Investment Amount into Conversion Shares
may require such Investor’s execution of certain agreements relating to the purchase and sale of such securities as well as registration,
co-sale, rights of first refusal, rights of first offer and voting rights, if any, relating to such shares. The Investor agrees to execute
all such agreements as the “Investor” in connection with the conversion so long as the issuance of Conversion Shares issued
pursuant to the conversion of the Investment Amount are subject to the same terms and conditions applicable to the shares sold in the
Qualified Financing, Non-Qualified Financing or financing relating to the Most Senior Shares, as the case may be and the terms and conditions
in such agreements or otherwise are no less favorable to the Investor than as set forth in the documents executed by the Investor in
connection with the prior equity financing for the Company prior to the date of this Agreement. Without derogating from the foregoing,
the Investor shall be deemed the “Investor” in connection with the conversion hereunder and be deemed a party to all such
financing agreements whether or not the Investor actually executes such agreements provided that notwithstanding anything to the contrary
in the financing agreements, the terms and conditions in such agreements are no less favorable to the Investor than as set forth in documents
previously executed by the Investor in connection with a prior equity financing for the Company prior to the date of this Agreement.

 

 5.  REPRESENTATIONS
AND WARRANTIES OF THE COMPANY.

 

The
Company hereby represents and warrants to the Investor that the following representations are true, correct and complete as of the date
hereof and as of the Closing (as if made on the Closing Date); except, in each case, as to such representations and warranties that address
matters as of a particular date, which are given only as of such date:

 

5.1
Organization. The Company is a company duly organized and validly existing under the laws of the State of Israel, is not a “breaching
company” (within the meaning of Section 362.A of the Israeli Companies Law, 1999, as amended) and has all requisite corporate power
and authority to carry on its business as currently conducted.

 

5.2
Authorization. The Company has the full power and authority to execute and deliver this Agreement and the other agreements contemplated
hereby or which are ancillary hereto, and to consummate the transactions contemplated hereby, and each of this Agreement and the other
agreements contemplated hereby or which are ancillary hereto, when executed and delivered by the Company, and assuming the due authorization,
execution and delivery by the other parties hereto and thereto, constitutes valid and binding obligations of the Company, enforceable
against the Company in accordance with their respective terms except (i) as limited by applicable bankruptcy, insolvency, reorganization,
moratorium, fraudulent conveyance, or other laws of general application relating to or affecting the enforcement of creditors’
rights generally, and (ii) as limited by laws relating to the availability of specific performance, injunctive relief, or other equitable
remedies.

 

5.3 No
Conflict; Consents. The execution, delivery and performance of this Agreement and the consummation of the transactions
contemplated hereby will not (a) result in any conflict with, or a breach or violation, with or without the passage of time and
giving of notice, of any of the terms, conditions or provisions of, or give rise to rights to others (including rights of
termination, cancellation or acceleration) under: (i) the Existing Articles; (ii) any judgment, injunction, order, writ, decree or
ruling of any court or governmental authority, domestic or foreign, to which the Company is subject; (iii) any material contract or
agreement, lease, license or commitment to which the Company is a party or by which it is bound; or (iv) any applicable law; (b)
result in the creation of any lien, charge or encumbrance upon any assets of the Company or the suspension, revocation, forfeiture,
or nonrenewal of any material permit or license applicable to the Company; or (c) except as may be required under that certain Loan
and Security Agreement dated as of February 19, 2017, by and between Silicon Valley Bank, the Company and Beamr, Inc., require the
consent, approval or authorization of, registration, qualification or filing with, or notice to any person or any federal, state,
local or foreign governmental authority or regulatory authority or agency, on the part of the Company, which has not heretofore been
obtained or will be obtained prior to Closing.

 

    4

     

    

 

5.4
Share Capital. The authorized share capital of the Company as of the date hereof and as of the Closing is as set forth in the
Existing Articles, and the issued and outstanding share capital of the Company, on a fully diluted as converted basis as of the date
hereof and as of the Closing, is set forth in Schedule 5.4. The issued and outstanding shares of the Company were duly and validly
authorized and issued, fully paid and non-assessable, and offered and issued in compliance with the provisions of the Company’s
Articles of Association as in effect at the time of each such issuance and in compliance with all applicable corporate and securities
laws. Other than as set forth in this Agreement or in Schedule 5.4, and except for (i) the conversion privileges of the Conversion
Shares pursuant to the Articles; (ii) the preemptive rights and bring-along provisions under applicable law or in the Articles; (iii)
Ordinary Shares reserved for issuance upon conversion of the Conversion Shares pursuant to the Articles, there are no outstanding share
capital, options, warrants, rights (including conversion, preemptive rights, rights of first refusal or similar rights) or agreements
for the purchase from the Company of any of its share capital, or any securities convertible into or exchangeable for shares of the Company
(whether now or hereinafter authorized or issued), or that could require the Company or a shareholder of the Company to issue, sell,
transfer or otherwise cause to be outstanding any of the Company’s share capital or securities convertible or exercisable into
shares thereof.

 

5.5
Valid Issuance. Upon any conversion of the Investment Amount as set forth herein, the Conversion Shares shall be duly and validly
issued, fully paid, and non-assessable, issued in compliance with all applicable state securities laws, and free and clear of liens,
pledges, charges, encumbrances or other restrictions on transfer of any kind (including, without limitation, preemptive rights), other
than as may be specified in the definitive agreements governing the transaction upon which such conversion shall occur pursuant to Section
3 above and under applicable securities laws and other than liens or encumbrances created by or imposed on the Investor as to itself.

 

5.6
Litigation. There is no claim, action, suit, proceeding, arbitration, complaint, charge or, to the Company’s knowledge,
investigation pending, or, to the Company’s knowledge, currently threatened in writing against the Company, any of its properties
or any officer, director or employee of the Company, or that questions the validity of the Agreement or the right of the Company to enter
into it, or to consummate the transactions contemplated by the Agreement. Neither the Company nor, to the Company’s knowledge,
any of its officers, directors, consultants or employees is a party to or is named as subject to the provisions of any order, writ, injunction,
judgment or decree of any court or government agency or instrumentality (in the case of officers, directors or employees, such as would
affect the Company). There is no action, suit, proceeding or investigation by the Company pending or which the Company intends to initiate.
The foregoing includes, without limitation, actions, suits, proceedings or investigations pending or, to the Company’s knowledge,
threatened in writing (or any basis therefor known to the Company) involving the prior engagement of any of the Company’s employees
their services provided in connection with the Company’s business, any information or technologies allegedly proprietary to any
of their former employers or their obligations under any agreements with former employers.

 

5.7
Compliance with Laws and Other Instruments. The Company is, and has been, in compliance, in all material respects, with all applicable
laws. The Company has not received any written notice of or been charged with the violation of any law and, to Company’s knowledge,
there is no threatened action or proceeding against the Company under any of such laws. The Company is not in violation of or default
under (i) any provisions of the Existing Articles, (ii) any order, writ, injunction, decree, or judgment of any court or any governmental
department, commission or agency, domestic or foreign, to which it is subject or by which it is bound. The Company has obtained all franchises,
permits, licenses, consents and any similar authorizations that are material to its business as currently conducted under applicable
law, and is in compliance, in all material respects, with such franchises, permits, licenses, consents and similar authorizations. None
of the Company’s products, intellectual property or operations is subject to any restriction or limitation or requires a license
or registration under applicable laws relating to marketing, export or import controls. Without limiting the generality of the foregoing,
the Company has not and is not using or developing, or is engaged in, encryption technology, or other technology whose development, commercialization
or export is restricted, and the conduct of the business as currently conducted does not require obtaining a license from the Israeli
Ministry of Defense or an authorized body thereof pursuant to Section 2(a) of the Control of Products and Services Declaration (Engagement
in Encryption), 1974, or from the Israeli Ministry of Economy pursuant to the Law of Regulation of Security Exports, 2007.

 

    5

     

    

 

 6.  REPRESENTATIONS
AND WARRANTIES OF THE INVESTOR.

 

The
Investor hereby represents and warrants that the following representations are true, correct and complete as of the date hereof and as
of the Closing (as if made on the Closing Date) and as of the date of the issuance of the Conversion Shares; except, in each case, as
to such representations and warranties that address matters as of a particular date, which are given only as of such date:

 

6.1
Authorization; Organization. The Investor is duly organized, validly existing and, if applicable, in good standing under the laws
of the jurisdiction in which it has been incorporated and has full power and authority to enter into this Agreement. This Agreement when
executed and delivered by the Investor, and assuming the due authorization, execution and delivery by the other parties hereto, constitute
valid and binding obligations of the Investor, enforceable against the Investor in accordance with its terms, except (i) as limited by
applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, or other laws of general application relating to
or affecting the enforcement of creditors’ rights generally, and (ii) as limited by laws relating to the availability of specific
performance, injunctive relief, or other equitable remedies.

 

6.2
Purchase Entirely for Own Account. The Conversion Shares to be issued upon conversion hereunder and the Ordinary Shares issued
upon conversion thereof (the “Conversion Securities”) will be acquired for investment for the Investor’s own
account, not as a nominee or agent, and not with a view to the resale or distribution of any part thereof, and the Investor has no present
intention of selling, granting any participation in, or otherwise distributing the same. The Investor does not presently have any contract,
undertaking, agreement or arrangement to sell, transfer or grant participation rights to any person with respect to any of the Conversion
Securities. The Investor has not been formed for the specific purpose of acquiring the Conversion Securities.

 

6.3
Disclosure of Information. The Investor has had an opportunity to discuss the Company’s business, operations, properties,
prospects, technology, plans, management, financial affairs and the terms and conditions of the offering of the Conversion Shares with
the Company’s management and has had an opportunity to review the Company’s facilities. The foregoing, however, does not
limit, modify or qualify the representations and warranties of the Company in Section 4.6 of this Agreement or the right of the Investor
to rely thereon. The Investor acknowledges that any projections provided (if any) by the Company are uncertain in nature, and that some
or all of the assumptions underlying such projections may not materialize or will vary significantly from actual results.

 

6.4
Investment Experience; Accredited Investor; Non-U.S. Person. The Investor is an investor in securities of companies in the development
stage and acknowledges that it is able to fend for itself, can bear the economic risk of its investment, and has such knowledge and experience
in financial or business matters that it is capable of evaluating and understanding the merits and risks of the investment in the Conversion
Shares. The Investor is either (i) an accredited investor as defined in Rule 501(a) of Regulation D promulgated under the Securities
Act of 1933 (together with the rules and regulations promulgated thereunder, all as amended, the “Securities Act”),
or (ii) a Non U.S. Person as defined under Regulation S promulgated under the Securities Act. To the extent that the Investor is a non
U.S. Person, the Investor (x) is not acquiring Conversion Securities for the account or benefit of any U.S. Person, (y) is not, at the
time of execution of this Agreement, and will not be, at the time of the issuance of the Conversion Securities, in the United States
and (z) is not a “distributor” (as defined in Regulation S promulgated under the Securities Act).

 

6.5
Restricted Securities. The Conversion Securities will not be registered under the Securities Act or any state securities laws
and, therefore, cannot be resold unless they are registered under the Securities Act and applicable state securities laws or unless an
exemption from such registration requirements is available. Investor is aware that the Company is under no obligation to effect any such
registration or to file for or comply with any exemption from registration. The sale and issuance of the Conversion Securities have not
and will not be registered under the Securities Act by reason of a specific exemption from registration which depends upon, among other
things, the accuracy of the Investor’s representations as expressed herein.

 

    6

     

    

 

6.6 Legends.
The Conversion Securities, and (if applicable) any securities issued in respect of or exchange for the foregoing may be notated with
the following or a similar legend as well as other legends as may be required by applicable securities laws: “THE SHARES
REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A
VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO TRANSFER OF SUCH SHARES MAY BE EFFECTED WITHOUT AN EFFECTIVE
REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT
REQUIRED UNDER THE SECURITIES ACT OF 1933.”

 

 7.  CONDITIONS
TO CLOSING.

 

The
obligation of the Investor to disburse the Investment Amount to the Company on the Closing Date is subject to the fulfillment on or before
the Closing of each of the following conditions, unless otherwise waived in writing by the Investor:

 

(a)
Performance. The Company shall have performed and complied with all agreements, obligations and conditions contained in this Agreement
that are required to be performed or complied with by it on or before the Closing.

 

(b)
Consents, etc. The Company shall have secured at or prior to the Closing, all permits, consents and authorizations that shall
be necessary or required lawfully to consummate this Agreement and the transactions contemplated by this Agreement.

 

(c)
Delivery of Documents. All of the documents to be delivered by the Company pursuant to Section 2.2(a) shall be in a form as attached
to this Agreement, or in a form and substance satisfactory to the Investor and shall have been delivered to the Investor.

 

 8.  CERTAIN
EVENTS.

 

Notwithstanding
anything herein to the contrary, unless earlier converted/repaid pursuant to Section 3 above, subject to the Company’s obligations
towards Silicon Valley Bank, the Investment Amount shall immediately become due and payable in cash by the Company upon an occurrence
of a Certain Event (as defined below). Each of the following shall constitute a “Certain Event”:

 

8.1
The Company files any petition or action for relief under any bankruptcy, reorganization, insolvency or moratorium law or any other law
for the relief of, or relating to, debtors, now or hereafter in effect (collectively “Bankruptcy Laws”), or makes
any assignment for the benefit of creditors or takes any corporate action in furtherance of any of the foregoing and such actions are
not stayed, enjoined, or discharged within forty five (45) days from their commencement;

 

8.2
The appointment of a receiver or trustee over the whole or any part of the Company’s assets and such appointment is not stayed,
enjoined or discharged within forty five (45) days from its commencement;

 

8.3
The calling by Company of a meeting of creditors for the purpose of entering into a scheme or arrangement with them;

 

8.4
Any involuntary petition or proceeding under any Bankruptcy Laws is instituted against the Company, which has not been terminated within
forty five (45) days thereafter;

 

8.5
The transaction of the business of the Company is suspended, substantially curtailed or ceased for a period longer than forty five (45)
days; or

 

8.6
The Company adopts one or more resolutions for dissolution, liquidation, bankruptcy or winding-up of the Company.

 

The
Company shall notify the Investor in writing immediately upon the occurrence of any such Certain Event (without regard to any grace or
cure period specified therein).

 

    7

     

    

 

 9.  MISCELLANEOUS.

 

9.1
Taxes. The Investor shall bear and be responsible to pay in cash (to the Company or the relevant tax authorities, as applicable)
all taxes attributable to it, if any, in connection with or as a result of the transactions contemplated under this Agreement.

 

9.2
Survival. The warranties, representations and covenants of the Company and of the Investor contained in or made pursuant to this
Agreement shall survive the Closing

 

9.3
Entire Agreement. This Agreement and the Schedules hereto constitute the full and entire understanding and agreement between the
parties with regard to the subject matters hereof, and supersede all prior agreements and understandings, both written and oral, among
any of the parties hereto, with respect to the subject matter hereof (with no concession being made as to the existence of any such prior
agreements or understandings).

 

9.4
Amendment; Waiver. Any term of this Agreement may be amended and the observance of any term hereof may be waived only with the
written consent of the Company and the Investor. The observance of any term hereof may be waived (either prospectively or retroactively
and either generally or in a particular instance) only by the prior written consent of the party against which enforcement of such waiver
shall be sought. Any amendment or waiver effected in accordance with this Section 9.4 shall be binding upon the Investor and each transferee
of the Conversion Shares (or the Ordinary Shares issuable upon conversion thereof), each future holder of all such securities, and the
Company.

 

9.5
Assignment. This Agreement may not be assigned by the Investor or the Company, without the prior written consent of the Investor
or the Company, as the case may be; however, the Investor may assign or transfer its rights, privileges, or obligations set forth in,
arising under, or created by this Agreement to its “Permitted Transferees” as defined in the Articles, provided, however,
that any such Permitted Transferee agrees in writing, prior to or at such assignment or transfer, to be bound by all agreements, warranties
and representations binding upon the Investor under this Agreement. Subject to the foregoing restriction, this Agreement shall inure
to the benefit of the Company and the Investor, and their respective successors, assigns and representatives.

 

9.6
Governing Law; Jurisdiction. This Agreement shall be governed by and construed in accordance with to the laws of the State of
Israel, disregarding its conflict of laws rules. Any dispute arising under or in relation to this Agreement shall be resolved exclusively
in the competent court located in Tel Aviv-Jaffa, Israel and each of the parties hereby irrevocably submits to the exclusive jurisdiction
of such court. Each of the parties hereto (i) consents to submit itself to the exclusive jurisdiction of the abovementioned courts in
the event any dispute arises out of this Agreement or the transactions contemplated by this Agreement, (ii) agrees that it shall not
attempt to deny or defeat such jurisdiction by motion or other request for leave from the abovementioned court, (iii) agrees that it
shall not bring any action relating to this Agreement or the transactions contemplated by this Agreement in any court other than the
abovementioned court, and (iv) irrevocably consents to service of process in the manner provided by Section 9.10 or as otherwise provided
by applicable law.

 

9.7
Delays or Omissions. Except as expressly provided herein, no delay or omission to exercise any right, power or remedy accruing
to any party to this Agreement upon any breach or default of any other party under this Agreement, shall impair any such right, power
or remedy of such non-defaulting party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein,
or of any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of
any other breach or default therefore or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the
part of any party of any breach or default under this Agreement, or any waiver on the part of any party of any provisions or conditions
of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies,
either under this Agreement or by law or otherwise afforded to any party to this Agreement, shall be cumulative and not alternative.

 

    8

     

    

 

9.8 Interpretation.
The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing or
interpreting this Agreement. The words “include”, “includes” and “including” shall be deemed to
be followed by the phrase “without limitation”. Unless the context requires otherwise, the words “herein”,
“hereof” and “hereunder”, and words of similar import, shall be construed to refer to this Agreement in its
entirety, and not to any particular provision hereof, and all references herein to Sections shall be construed to refer to Sections
to this Agreement. Reference to “governmental authorities” (or similar terms) shall include any: (a) nation,
principality, state, commonwealth, territory, county, municipality, district or other jurisdiction of any nature, (b) federal,
state, local, municipal, foreign or other government, (c) governmental, quasi governmental or regulatory body of any nature,
including any governmental division, subdivision, department, agency, bureau, branch, office, commission, council, board,
instrumentality, organization, unit, or body, or (d) court, public or private arbitrator or other public tribunal. Reference to a
“person” shall mean any individual, corporation, partnership, limited liability company, firm, joint venture,
association, joint-stock company, trust, estate, unincorporated organization, governmental authority or other entity, including, any
party to this Agreement. Any reference to a “day” or a number of days (without explicit reference to “business
days”) shall be interpreted as a reference to a calendar day or number of calendar days, and if any action is to be taken or
given on or by a particular calendar day, and such calendar day is not a business day, then such action may be deferred until the
first business day thereafter (where “business day” shall mean any day on which banking institutions in Tel-Aviv-Jaffa,
Israel are generally open to the public for conducting business and are not required by law to close).

 

9.9
Severability. If one or more provisions of this Agreement are held to be unenforceable under applicable law, such provision shall
be excluded from this Agreement and the balance of the Agreement shall be enforceable in accordance with its terms and interpreted so
as to give effect, to the fullest extent consistent with and permitted by applicable law, to the meaning and intention of the excluded
provision.

 

9.10 Notices.
All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed effectively
given upon the earlier of actual receipt, or (i) when delivered, if sent by personal delivery to the party to be notified, (ii) when
sent, if sent by electronic mail or facsimile (with electronic conformation of delivery) on a business day and during normal
business hours of the recipient, and otherwise on the first business day in the place of recipient, (iii) five (5) business days
after having been sent, if sent by registered or certified mail, return receipt requested, postage prepaid, or (iv) one (1) business
day after deposit with an internationally recognized overnight courier, freight prepaid, specifying next business day delivery, with
written confirmation of receipt. All communications shall be sent to the respective parties at their address or contact details as
set forth below, or to such address or contact details as subsequently modified by written notice given in accordance with this
Section 9.10, or, in the case of the Investor, as used for purposes of sending shareholders’ notices by the
Company.

 

If
to the Company:

 

Beamr
Imaging Ltd.

10
Hamenofim Street,

Herzeliya
Pituach 4672561

Israel

Attention:
Sharon Carmel

Telephone:

E-mail:Sharon@beamr.com

 

If
to Investor: as set forth on Schedule 1 hereto.

 

9.11
Counterparts. This Agreement may be executed in one or more counterparts, all of which together shall constitute one and the same
instrument, binding and enforceable against the parties so executing the same; it being understood that all parties need not sign the
same counterpart. Counterparts may also be delivered by facsimile or email transmission (in pdf format or the like, or signed with DocuSign
or any similar form of signature by electronic means) and any counterpart so delivered shall be sufficient to bind the parties to this
Agreement, as an original.

 

[Signature
Pages Follow]

 

    9

     

    

 

IN
WITNESS WHEREOF, the undersigned have caused this Advance Investment Agreement to be executed by their respective duly authorized officers
as of the date first above written.

 

	COMPANY:	 
	 	 
	 	 
	Beamr
    Imaging Ltd.	 
	 	 
	By:·	               	 
	Name: 	Sharon
    Carmel	 
	Title:	CEO	 

 

[Signature
Page to Advance Investment Agreement/Beamr Imaging Ltd.]

 

    10

     

    

 

IN
WITNESS WHEREOF, the undersigned have caused this Advance Investment Agreement to be executed by their respective duly authorized officers
as of the date first above written.

 

	INVESTOR:	 
	 	 
	 	 
	 	 
	By:· 	              	 

 

[Signature
Page to Advance Investment Agreement/Beamr Imaging Ltd.]

 

    11

     

    

 

Schedule
1

 

The
Investor

 

	Investor	Address	Investment
    Amount (US$)
	 	 	 
	 	 	 
	 	 	 

 

 

12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00340-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00340-of-00352.parquet"}]]